Medacta Group SA

Equities

MOVE

CH0468525222

Medical Equipment, Supplies & Distribution

Market Closed - Swiss Exchange Other stock markets 09:00:08 17/07/2024 pm IST			5-day change	1st Jan Change
121 ^CHF	-1.14%		-0.17%	-3.66%

13/03	Medacta Group SA Proposes Distribution	CI
13/03	Medacta Group SA Provides Earnings Guidance for the Year 2024	CI

Medacta Group SA Announces Preliminary Unaudited Sales Results for the Year 2019

January 21, 2020 at 11:45 am IST

Medacta Group SA announced preliminary unaudited sales results for the year 2019. The company realized 2019 preliminary unaudited sales equal to Euro 311 million, with an increase of 14.0% over the prior year (11.4% on a constant currency basis).

Latest news about Medacta Group SA

Medacta Group SA Proposes Distribution	13/03	CI
Medacta Group SA Provides Earnings Guidance for the Year 2024	13/03	CI
Transcript : Medacta Group SA, 2023 Earnings Call, Mar 13, 2024	13/03
Medacta Group Records Higher FY23 Attributable Profit, Revenue	13/03	MT
Medacta Group SA Reports Earnings Results for the Full Year Ended December 31, 2023	13/03	CI
Medacta Enters Collaboration for RFID Technology in Healthcare Business	20/02	MT
Transcript : Medacta Group SA, 2023 Sales/ Trading Statement Call, Feb 02, 2024	02/02
Medacta Group Books 17% Jump in FY23 Revenue	02/02	MT
Medacta to Expand Swiss Facilities to Boost Production Capacity	30/11	MT
Medacta Group to Launch Optimized Knee Implant	30/23/30	MT
Medacta's New Study Shows Accuracy of NextAR Shoulder Application	13/23/13	MT
Transcript : Medacta Group SA, Q2 2023 Earnings Call, Sep 22, 2023	22/23/22
Medacta Group Reports Higher H1 Attributable Profit, Revenue	22/23/22	MT
Medacta Group SA Reports Earnings Results for the Half Year Ended June 30, 2023	21/23/21	CI
Transcript : Medacta Group SA, H1 2023 Sales/ Trading Statement Call, Jul 28, 2023	28/23/28
Medacta Posts 21% Increase in H1 Revenue; Raises FY23 Guidance	28/23/28	MT
Medacta Group SA Announces Unaudited Revenue Results for the First Half Ended June 30, 2023	28/23/28	CI
Medacta Group SA Updates Revenue Guidance for the Year 2023	28/23/28	CI
Global markets live: Enel, ASML, Adobe, Nikola...	05/23/05
Medacta Group Completes First MyPAO Surgery in Europe	05/23/05	MT
Exclusive-EQT sounds out banks to manage LimaCorporate IPO - sources	04/23/04	RE
Medacta Group SA Approves Distribution for the Year 2022	27/23/27	CI
Medacta's MySpine Platform Shows Accuracy for Pedicle Screw Placement in Clinical Study	21/23/21	MT
Medacta Group SA Provides Earnings Guidance for the Year 2023	17/23/17	CI
Medacta Group SA Proposes Dividend	17/23/17	CI

Chart Medacta Group SA

Duration

Period

More charts

Company Profile

Medacta International SA is a Swiss-based company specialized in medical devices. The Company develops, manufactures and distributes orthopaedic and neurosurgical medical devices. The Company designs a number of products, such as hip products, including hip replacement, hip anatomy, hip diseases, and other products for the preparation of hip surgery; knee product, which encompasses knee anatomy, knee diseases, knee replacement, the stability of the knee and for the preparation of knee surgery; shoulder product, which includes shoulder anatomy, shoulder disease, shoulder replacement, and for the preparation of shoulder operation, and spine product, which includes products for spinal treatments, spinal anatomy and for surgery, among others. Additionally, the Company also offers training and support to healthcare professionals.

Sector

Medical Equipment, Supplies & Distribution

Calendar

26/07/2024 - Q2 2024 Sales and Revenue Release

More about the company

Income Statement Evolution

More financial data

Ratings for Medacta Group SA

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

125 EUR

Average target price

145.3 EUR

Spread / Average Target

+16.21%

Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
MEDACTA GROUP SA	-3.66%	272.42Cr
ABBOTT LABORATORIES	-4.90%	18TCr
MEDTRONIC PLC	-1.36%	10TCr
DEXCOM, INC.	-7.64%	4.56TCr
HOYA CORPORATION	+9.30%	4.64TCr
CENCORA, INC.	+9.63%	4.43TCr
METTLER-TOLEDO INTERNATIONAL, INC.	+13.63%	2.94TCr
TERUMO CORPORATION	+20.29%	2.68TCr
WEST PHARMACEUTICAL SERVICES, INC.	-7.12%	2.38TCr
STERIS PLC	+4.03%	2.26TCr

Other Medical Equipment, Supplies & Distribution